文献速递乳腺癌

大型弱势亚群全国乳腺X线筛查率研究

Nationwide Mammographic Screening Among a Large Population of Underserved Subgroups.
PubMed 文献 · J Clin Oncol · 2026-03-03

本研究基于OptumLabs数据,比较跨性别与性别多元(TGD)个体与顺性别女性的乳腺X线筛查率。结果显示跨性别男性高筛查率41.1%,跨性别女性7.4%,性别烦躁未满足其他TGD标准者11.9%,顺性别女性38.3%(P<.0001)。匹配分析中跨性别男性在40-49岁和50-59岁高筛查率高于顺性别女性。

要点

  • 跨性别男性高筛查率41.1%,与顺性别女性38.3%相近。
  • 跨性别女性高筛查率仅7.4%,提示低风险人群筛查不足。
  • 跨性别男性40-59岁高筛查率高于匹配顺性别女性。

核心结论

  • 顺性别女性和跨性别男性筛查率相对较高,提示临床医生对平均或高风险乳腺癌风险者提供乳腺X线筛查。
  • 跨性别女性低风险者筛查率低,未过度筛查。

研究设计与样本

  • 基于OptumLabs纵向数据仓库的全国性研究。
  • 纳入符合美国放射学会指南筛查条件的TGD个体10,478例和顺性别女性6,218,369例。
  • 匹配分析按1:4比例匹配跨性别男性与顺性别女性,匹配因素包括年龄、种族/民族、入组年份和随访时长。

主要发现

  • 跨性别男性高筛查率41.1%(95% CI, 39.5 to 42.6)。
  • 跨性别女性高筛查率7.4%(95% CI, 6.0 to 8.8)。
  • 性别烦躁未满足其他TGD标准者高筛查率11.9%(95% CI, 11.0 to 12.7)。
  • 顺性别女性高筛查率38.3%(95% CI, 38.3 to 38.4),组间比较P<.0001。
  • 匹配分析中,跨性别男性对比顺性别女性,年龄与高筛查率存在交互作用(交互P=.0003);40-49岁OR=1.38(95% CI, 1.28 to 1.50),50-59岁OR=1.57(95% CI, 1.35 to 1.81),均P<.0001,老年组无差异。

关键数值与推荐

  • 高筛查率定义为>75%推荐筛查。
  • 筛查资格基于美国放射学会指南。

临床怎么用

  • 临床医生应继续为跨性别男性提供适龄乳腺X线筛查。
  • 关注跨性别女性低风险人群的筛查需求,避免过度或不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This national study was undertaken to determine screening mammography rates among transgender and gender diverse (TGD) individuals. METHODS: TGD individuals and cisgender women who qualified to receive screening mammography based on American College of Radiology guidelines were identified in the longitudinal OptumLabs Data Warehouse. The primary end point was the percentage of patients who had high rates of screening (>75% recommended screenings). Multivariable analyses were conducted in a matched population of transgender men to cisgender women to identify and adjust for factors associated with high adherence. Individuals were matched at a 1:4 ratio (transgender men: cisgender women) on age, race/ethnicity, year of enrollment in their health care plan, and duration of follow-up. RESULTS: This study focused on 10,478 TGD individuals (3,778 transgender men; 1,294 transgender women; 5,406 with gender dysphoria not meeting other TGD criteria, NMOT) and 6,218,369 cisgender women. For transgender men, transgender women, individuals with gender dysphoria NMOT, and cisgender women, high mammography rates were observed in 41.1% (95% CI, 39.5 to 42.6), 7.4% (95% CI, 6.0 to 8.8), 11.9% (95% CI, 11.0 to 12.7), and 38.3% (95% CI, 38.3 to 38.4), respectively (P < .0001). When transgender men were compared with 15,112 matched cisgender women, an age-based differential association was observed between sex and high mammography rates (interaction P = .0003); compared with cisgender women, transgender men appeared more likely to manifest high rates of screening at age 40-49 years (odds ratios [ORs], 1.38 [95% CI, 1.28 to 1.50]; P < .0001) and 50-59 years (OR, 1.57 [95% CI, 1.35 to 1.81]; P < .0001) but not in the older age groups. CONCLUSION: The relatively high rates of screening mammography in cisgender women and transgender men suggest clinicians are offering mammography to individuals who are at average or high breast cancer risk, as compared with cisgender women, and not to transgender women at low risk.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Cathcart-Rake EJ, Thao V, Le-Rademacher J, et al. Nationwide Mammographic Screening Among a Large Population of Underserved Subgroups. J Clin Oncol. 2026. PMID: 41774876. doi:10.1200/JCO-25-01659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。